Pharmacogenomic testing for neuropsychiatric drugs: current status of drug labeling, guidelines for using genetic information, and test options.

Pharmacogenomic testing for neuropsychiatric drugs: current status of drug labeling, guidelines for using genetic information, and test options.
复制标题

DOI:
10.1002/phar.1398
复制
发表时间:
2014-02
期刊:
影响因子:
4.1
通讯作者:
Bishop, Jeffrey R.
Bishop, Jeffrey R.
中科院分区:
医学2区
文献类型:
--
作者:
Drozda, Katarzyna;Mueller, Daniel J.;Bishop, Jeffrey R.

文献摘要

参考文献

被引文献

相似文献

药物基因组学的进步带来了越来越多的机会将个性化医疗引入临床实践。了解如何以及何时使用这项技术来帮助指导用于治疗神经精神疾病的药物治疗仍然是许多临床医生面临的挑战。目前,已有指南帮助临床医生使用遗传信息来选择三环类抗抑郁药、卡马西平和苯妥英的药物和/或剂量。产品标签中的其他语言表明,遗传信息也可能有助于评估用于治疗精神和神经系统疾病的许多其他药物的起始剂量和目标剂量以及药物相互作用的可能性。在这篇综述中,我们概述了神经精神药物药物基因组学测试的现状,因为它涉及药物标签、共识指南和测试组中包含的信息,以及与为患者进行测试相关的考虑因素。
Advancements in pharmacogenomics have introduced an increasing number of opportunities to bring personalized medicine into clinical practice. Understanding how and when to use this technology to help guide pharmacotherapy used to treat neuropsychiatric conditions remains a challenge for many clinicians. Currently, guidelines exist to assist clinicians in the use of genetic information for drug selection and/or dosing for the tricyclic antidepressants, carbamazepine, and phenytoin. Additional language in the product labeling suggests that genetic information may also be useful for assessing the starting and target doses, as well as drug interaction potential, for a number of other medications used to treat psychiatric and neurological conditions. In this review, we outline the current status of pharmacogenomic testing for neuropsychiatric drugs as it pertains to information contained in drug labeling, consensus guidelines, and test panels, as well as considerations related to obtaining tests for patients.
DOI: 10.1038/clpt.2013.2
发表时间: 2013-05-01
影响因子: 6.7
作者:
Hicks, J. K.;Swen, J. J.;Stingl, J. C.
通讯作者: Stingl, J. C.
DOI: 10.1093/nar/gkq1128
发表时间: 2011-01
影响因子: 14.9
作者:
Gonzalez-Galarza FF;Christmas S;Middleton D;Jones AR
通讯作者: Jones AR
DOI: 10.1176/appi.psy.47.1.75
发表时间: 2006-02-01
期刊: PSYCHOSOMATICS
影响因子: 3.4
作者:
De Leon, J;Armstrong, SC;Cozza, KL
通讯作者: Cozza, KL
DOI: 10.3390/jpm2040201
发表时间: 2012-10-30
影响因子: --
作者:
Hresko A;Haga SB
通讯作者: Haga SB
DOI: 10.1097/gim.0b013e31815bf9a3
发表时间: 2007-12-01
影响因子: 8.8
作者:
Berg, Alfred O.;Piper, Margaret;Teutsch, Steven
通讯作者: Teutsch, Steven